AMLX
Price
$13.97
Change
-$0.10 (-0.71%)
Updated
Jan 15, 11:09 AM (EDT)
Capitalization
1.55B
76 days until earnings call
Intraday BUY SELL Signals
AVDL
Price
$21.53
Change
+$0.03 (+0.14%)
Updated
Jan 15, 11:12 AM (EDT)
Capitalization
2.11B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs AVDL

Header iconAMLX vs AVDL Comparison
Open Charts AMLX vs AVDLBanner chart's image
Amylyx Pharmaceuticals
Price$13.97
Change-$0.10 (-0.71%)
Volume$200
Capitalization1.55B
Avadel Pharmaceuticals
Price$21.53
Change+$0.03 (+0.14%)
Volume$676
Capitalization2.11B
AMLX vs AVDL Comparison Chart in %
View a ticker or compare two or three
VS
AMLX vs. AVDL commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and AVDL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AMLX: $14.07 vs. AVDL: $21.50)
Brand notoriety: AMLX: Not notable vs. AVDL: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMLX: 117% vs. AVDL: 86%
Market capitalization -- AMLX: $1.55B vs. AVDL: $2.11B
AMLX [@Pharmaceuticals: Generic] is valued at $1.55B. AVDL’s [@Pharmaceuticals: Generic] market capitalization is $2.11B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.17B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileAVDL’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • AVDL’s FA Score: 0 green, 5 red.
According to our system of comparison, AVDL is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while AVDL’s TA Score has 2 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 6 bearish.
  • AVDL’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, AVDL is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а +17.35% price change this week, while AVDL (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.60%. For the same industry, the average monthly price growth was +8.77%, and the average quarterly price growth was +19.20%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

AVDL is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.60% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVDL($2.11B) has a higher market cap than AMLX($1.55B). AMLX YTD gains are higher at: 16.474 vs. AVDL (-0.232). AVDL has higher annual earnings (EBITDA): 10.1M vs. AMLX (-156.76M). AMLX has more cash in the bank: 344M vs. AVDL (91.6M). AVDL has less debt than AMLX: AVDL (2.55M) vs AMLX (5.94M). AVDL has higher revenues than AMLX: AVDL (249M) vs AMLX (-665K).
AMLXAVDLAMLX / AVDL
Capitalization1.55B2.11B73%
EBITDA-156.76M10.1M-1,552%
Gain YTD16.474-0.232-7,100%
P/E Ratio2.69N/A-
Revenue-665K249M-0%
Total Cash344M91.6M376%
Total Debt5.94M2.55M233%
FUNDAMENTALS RATINGS
AVDL: Fundamental Ratings
AVDL
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
41
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXAVDL
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 21 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
AVDL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICISX14.700.06
+0.41%
VY® Columbia Small Cap Value II I
FLCPX27.71N/A
N/A
Fidelity SAI US Large Cap Index
BABDX12.08-0.02
-0.17%
BlackRock Global Dividend Inv A
DGEYX26.53-0.05
-0.19%
BNY Mellon Global Emerging Mkts - Y
NGUAX29.61-0.35
-1.17%
Neuberger Large Cap Growth Inv

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+11.67%
XOMAO - AMLX
68%
Closely correlated
+0.47%
XOMAP - AMLX
51%
Loosely correlated
-1.43%
OCUL - AMLX
46%
Loosely correlated
+6.14%
LRMR - AMLX
45%
Loosely correlated
+2.40%
RGNX - AMLX
43%
Loosely correlated
-0.66%
More

AVDL and

Correlation & Price change

A.I.dvisor tells us that AVDL and RMTI have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVDL and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
+0.09%
RMTI - AVDL
33%
Poorly correlated
+0.75%
RDY - AVDL
28%
Poorly correlated
+0.61%
COLL - AVDL
27%
Poorly correlated
-1.50%
AMLX - AVDL
27%
Poorly correlated
+11.67%
ELAN - AVDL
26%
Poorly correlated
-0.04%
More